Wolf O. Bechstein

1988–2025 年に発表

121
論文数
26,724
被引用数
81
h 指数
116
i10 指数

被引用数

Wolf O. Bechstein の年別被引用数1939 年: 被引用 1 件1986 年: 被引用 1 件1989 年: 被引用 1 件1990 年: 被引用 6 件1991 年: 被引用 13 件1992 年: 被引用 6 件1993 年: 被引用 14 件1994 年: 被引用 12 件1995 年: 被引用 11 件1996 年: 被引用 31 件1997 年: 被引用 37 件1998 年: 被引用 41 件1999 年: 被引用 42 件2000 年: 被引用 50 件2001 年: 被引用 48 件2002 年: 被引用 54 件2003 年: 被引用 53 件2004 年: 被引用 66 件2005 年: 被引用 58 件2006 年: 被引用 69 件2007 年: 被引用 90 件2008 年: 被引用 116 件2009 年: 被引用 121 件2010 年: 被引用 143 件2011 年: 被引用 138 件2012 年: 被引用 152 件2013 年: 被引用 122 件2014 年: 被引用 140 件2015 年: 被引用 111 件2016 年: 被引用 109 件2017 年: 被引用 142 件2018 年: 被引用 116 件2019 年: 被引用 641 件2020 年: 被引用 770 件2021 年: 被引用 753 件2022 年: 被引用 559 件2023 年: 被引用 426 件2024 年: 被引用 818 件2025 年: 被引用 354 件2026 年: 被引用 7 件1940〜1985 年は被引用が無いため表示していません1987〜1988 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,775 件、この内訳の 19.6%中国: 引用元論文 841 件、この内訳の 9.3%ドイツ: 引用元論文 796 件、この内訳の 8.8%イタリア: 引用元論文 618 件、この内訳の 6.8%イギリス: 引用元論文 581 件、この内訳の 6.4%日本: 引用元論文 569 件、この内訳の 6.3%フランス: 引用元論文 463 件、この内訳の 5.1%オランダ: 引用元論文 431 件、この内訳の 4.8%スペイン: 引用元論文 287 件、この内訳の 3.2%カナダ: 引用元論文 269 件、この内訳の 3%スイス: 引用元論文 246 件、この内訳の 2.7%ベルギー: 引用元論文 206 件、この内訳の 2.3%
0%19.6%その他 21.7%

分野

  • Medicine90.1%
  • Biochemistry, Genetics and Molecular Biology5.9%
  • Immunology and Microbiology1.1%
  • Engineering0.7%
  • Materials Science0.7%
  • Physics and Astronomy0.3%
  • その他1.2%

トピック

  • Hepatocellular Carcinoma Treatment and Prognosis9%
  • Pancreatic and Hepatic Oncology Research6.2%
  • Gastric Cancer Management and Outcomes5.8%
  • Cholangiocarcinoma and Gallbladder Cancer Studies5.5%
  • Organ Transplantation Techniques and Outcomes3.9%
  • Colorectal Cancer Treatments and Studies3.6%
  • その他66%

共著者

全論文

検索で開く
  1. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dirk Behringer, Michael Heike, Daniel Pink, Christian Teschendorf, Carmen Löhr, Helga Bernhard, Gunter Schuch, Volker Rethwisch, Ludwig Fischer von Weikersthal, Jörg T. Hartmann, Michael Kneba, S Daum, Karsten Schulmann, J. Weniger, Sebastian Belle, Timo Gaiser, Fuat Oduncu, Martina Güntner, Wael Hozaeel, Alexander Reichart, Elke Jäger, Thomas Kraus, Stefan Mönig, Wolf O. Bechstein, Martin Schüler, Harald Schmalenberg, Ralf‐Dieter Hofheinz - The Lancet 2019 被引用: 2,583

  2. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , - The Lancet Oncology 2013 被引用: 1,316

  3. Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin‐Leo Hansmann, Peter J. Wild, Stephan Falk, Petra Hödl, A Serebrennikov, Sanja Schmeck, Vittorio Paolucci, Stephan Sahm, Martin Eichel, Giovanna Römer, W. Bank, Nicolas Moosmann, Jan Braess, P. Piso, Heinrich Wiesinger, Peter Kappl, Elisabeth Germer, Monika Warmuth‐Metz, Volker Kunzmann, Katica Krajinovic, Andreas Rosenwald, Thorsten Alexander Bley, Ulrich Stölzel, Manfred Dörne, L. Renziehausen, Joachim Boese-Land, Dietrich Meißner, D. Burchert, Olaf Dirsch, Jörg Olaf Habeck, Klaus Kirchhof, Christof Lamberti, B. J. Leibl, Andreas Gschwendtner, Godehard Lahmer, Marga Lang-Welzenbach, Werner Hohenberger, Thomas Kuhnt, Kirsten Papsdorf, Christian Wittekind, Christine Volkheimer, Frederik Wenz, Kirsten Merx, Stefan Post, Timo Gaiser, Ulrike Attenberger, Michael Geißler, Jörn Sträter, Helmut Gnann, Stefan Krämer, Michael Henke, Henning Schäfer, Philipp Manegold, Hannes Neeff, Peter Bronsert, Wolff Schmiegel, Michael Pohl, Christian Möllecken, Irenä us A. Adamietz, Richard Viehbahn, Andrea Tannapfel, Jens Freiberg‐Richter, Thorsten Jacobi, Wolfgang Wendt, Klaus Holzweißig, Thomas Kittner, Ullrich Graeven, Christiane Lange, U. Kania, Elisabeth Rösler ほか 28 名 - JAMA Oncology 2021 被引用: 354

  4. Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 被引用: 195

  5. Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alfred Königsrainer, Timo Gaiser, Peter Schirmacher, Wael Hozaeel, Alexander Reichart, Thorsten Oliver Goetze, Mark Sievert, Elke Jäger, Stefan Mönig, Andrea Tannapfel - The Lancet Oncology 2016 被引用: 739

  6. Colorectal Cancer Organoid–Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy Responses

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Florian R. Greten - Cancer Discovery 2023 被引用: 109

  7. Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 540

  8. Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2017 被引用: 474

  9. Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial

    著者: , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2017 被引用: 678

  10. Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Angela Schlitt, Susanne Beckebaum, Christian Graeb, Silvio Nadalin, Umberto Valente, Víctor Sánchez Turrión, Neville V. Jamieson, Tim Scholz, M. Colledan, Fred Fändrich, Thomas Becker, Gunnar Söderdahl, Olivier Chazouillères, Heikki Mäkisalo, Georges‐Philippe Pageaux, Rudolf Steininger, Thomas Soliman, Koert P. de Jong, Jacques Pirenne, Raimund Margreiter, Johann Pratschke, Antonio D. Pinna, Johann Hauss, Stefan Schreiber, Simone I. Strasser, Jürgen Klempnauer, Roberto Troisi, Sherrie Bhoori, Jan Lerut, Itxarone Bilbao, Christian Klein, Alfred Königsrainer, Darius F. Mirza, Gerd Otto, Vincenzo Mazzaferro, P. Neuhaus, Hans J. Schlitt - Transplantation 2015 被引用: 417

  11. Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer

    著者: , , , , , , , , , , , , , , , , , , , - JAMA 2007 被引用: 2,377

  12. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , - The Lancet 2008 被引用: 1,945

  13. CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 296

  14. Preoperative portal vein or portal and hepatic vein embolization: DRAGON collaborative group analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - British journal of surgery 2021 被引用: 100

  15. FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2–Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 被引用: 91

  16. mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonio Daniele Pinna, Jaques Pirenne, Johann Pratschke, James Powel, Markus Rentsch, Magnus Rizell, G. Rossi, Lionel Rostaing, André Roy, Tim Scholz, Utz Settmacher, Thomas Soliman, Simone I. Strasser, Gunnar Söderdahl, Roberto Troisi, Víctor Sánchez Turrión, Hans J. Schlitt, Edward K. Geissler - Annals of Surgery 2020 被引用: 139

  17. The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction – a phase III trial of the German AIO/CAO-V/CAOGI

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas Zander, Hakan Alakus, Ralf‐Dieter Hofheinz, Claus Röedel, Manish A. Shah, Mitsuru Sasako, Dietmar Lorenz, Jakob R. Izbicki, Wolf O. Bechstein, Hauke Lang, Stefan Paul Moenig - BMC Cancer 2017 被引用: 228

  18. Randomized phase III trial of induction chemotherapy followed by chemoradiotherapy or chemotherapy alone for nonresectable locally advanced pancreatic cancer: First results of the CONKO-007 trial.

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 被引用: 114

  19. Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer

    著者: , , , , , , , , , , , , - Strahlentherapie und Onkologie 2014 被引用: 330

  20. Toward a Consensus on Centralization in Surgery

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Surgery 2018 被引用: 265

  21. Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2010 被引用: 714

  22. Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients

    著者: , , , , , , , , , , , , , , , , , , , - Transplantation 2017 被引用: 311

  23. Defining Major Surgery: A Delphi Consensus Among European Surgical Association (ESA) Members

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bertil Hamberger, J.F. Hamming, A. H. Hölscher, Jakob R. Izbicki, Sven Jonas, Aleksandar Karamarković, Henrik Kehlet, Ari Leppäniemi, Jan Lerut, Pål‐Dag Line, J. Peter A. Lodge, Jonathan Meakins, Marco Montorsi, Philippe Nafteux, Peter Naredi, Attila Oláh, Yves Panís, Fernando Pardo, Rowan W. Parks, Sergio Pedrazzoli, Patrick Pessaux, Hugo P. Marques, Gilberto Poggioli, Irinel Popescu, Pauli Puolakkainen, José Manuel Ramia, Jari Räsänen, John V. Reynolds, Riccardo Rosati, Hans‐Detlev Saeger, Stefan Schneeberger, Paul M. Schneider, Kjetil Søreide, Dirk L. Stippel, Christian Toso, Jean–Jacques Tuech, Erkki Tukiainen, Richard van Hillegersberg, Bas P. L. Wijnhoven, Desmond C. Winter, Giovanni Zaninotto - World Journal of Surgery 2020 被引用: 91

  24. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

    著者: , , , , , , , , , , , , , , , , , - The Lancet Oncology 2009 被引用: 960